Objective: We performed a multicentre study under a 2-year observational protocol that included data on time to recovery from acute exacerbations of chronic obstructive pulmonary disease (AE-COPD ...

Exacerbations of COPD are common and ... for 7–10 days recommended in current guidelines. Chronic obstructive pulmonary disease (COPD) is a condition of chronic airflow limitation that is ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

A study of primary care patients in 5 European countries found the mean antibiotic course duration for common respiratory ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

Chronic Obstructive Pulmonary Disease (COPD ... A study involving participants who had recently experienced an acute exacerbation of COPD demonstrated that wearable devices could effectively ...

Chronic obstructive pulmonary disease (COPD) is a chronic condition ... and a higher risk of COPD exacerbations. These are periods when your symptoms significantly worsen. Wheezing may also ...

A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD) has ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

Live webcasts for the events will also be accessible on Connect’s website in the Investors section under Presentations, Events & News at investors.connectbiopharm.com. An archived replay of the ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...